Immunogenicity and protective efficacy of a tuberculosis DNA vaccine co-expressing pro-apoptotic caspase-3

Vaccine

Volumn 26, Issue 11, 2008, Pages 1458-1470

  Gartner, Tatiana ^a,b,c   Romano, Marta ^c   Suin, Vanessa ^c   Kalai, Michaël ^c   Korf, Hannelie ^c   De Baetselier, Patrick ^a,b   Huygen, Kris ^c  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

Author keywords

Apoptosis; DNA vaccination; Tuberculosis

Indexed keywords

BCG VACCINE; CASPASE 3; CYTOKINE; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17A; INTERLEUKIN 2; INTERLEUKIN 6; MATURE MYCOLYL TRANSFERASE ANTIGEN 85A; MYCOLYL TRANSFERASE ANTIGEN 85A; SECRETED MYCOLYL TRANSFERASE ANTIGEN 85A; TUBERCULOSIS DNA VACCINE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA IMMUNIZATION; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; MEMORY CELL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SPLEEN CELL; WILD TYPE;

EID: 39749105221     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.12.056     Document Type: Article

References (42)

1. B.R. Bloom P.E.M. Fine The BCG experience: implications for future vaccines against tuberculosis A. Press Tuberculosis: pathogenesis, protection and control 1994 Bloom B R Washington, DC 531 557
2. K. Huygen J. Content O. Denis D.L. Montgomery A.M. Yawman R.R. Deck Immunogenicity and protective efficacy of a tuberculosis DNA vaccine Nat Med 2 August(8) 1996 893 898
3. A. Tanghe P. Lefevre O. Denis S. D'Souza M. Braibant E. Lozes Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors J Immunol 162 January 15(2) 1999 1113 1119
4. K. Huygen Plasmid DNA vaccination Microbes Infect 7 May(5/6) 2005 932 938
5. J. Keane H.G. Remold H. Kornfeld Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages J Immunol 164 February (154) 2000 2016 2020
6. U.E. Schaible F. Winau P.A. Sieling K. Fischer H.L. Collins K. Hagens Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis Nat Med 9 August(8) 2003 1039 1046
7. S. Sasaki R.R. Amara A.E. Oran J.M. Smith H.L. Robinson Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases Nat Biotechnol 19 June(6) 2001 543 547
8. M. Lamkanfi K. D’Hondt L. Vande Walle M. van Gurp G. Denecker J. Demeulemeester A novel caspase-2 complex containing TRAF2 and RIP1 J Biol Chem 280 February 25(8) 2005 6923 6932
9. A. Tinel S. Janssens S. Lippens S. Cuenin E. Logette B. Jaccard Autoproteolysis of PIDD marks the bifurcation between pro-death caspase-2 and pro-survival NF-kappaB pathway EMBO J 26 January 10(1) 2007 197 208
10. A. Tinel J. Tschopp The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress Science 304 May 7(5672) 2004 843 846
11. X. Saelens M. Kalai P. Vandenabeele Translation inhibition in apoptosis: caspase-dependent PKR activation and eIF2-alpha phosphorylation J Biol Chem 276 November 9(45) 2001 41620 41628
12. X. Saelens N. Festjens E. Parthoens I. Vanoverberghe M. Kalai F. van Kuppeveld Protein synthesis persists during necrotic cell death J Cell Biol 168 February 14(4) 2005 545 551
13. P.A. Colussi N.L. Harvey L.M. Shearwin-Whyatt S. Kumar Conversion of procaspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain J Biol Chem 273 October 9(41) 1998 26566 26570
14. S.L. Baldwin C.D. D'Souza I.M. Orme M.A. Liu K. Huygen O. Denis Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A Tuber Lung Dis 79 4 1999 251 259
15. + T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection Infect Immun 66 April(4) 1998 1527 1533
16. M.C. Schmid R. Schulein M. Dehio G. Denecker I. Carena C. Dehio The VirB type IV secretion system of Bartonella henselae mediates invasion, proinflammatory activation and antiapoptotic protection of endothelial cells Mol Microbiol 52 April(1) 2004 81 92
17. A. Drowart J. De Bruyn K. Huygen G. Damiani H.P. Godfrey M. Stelandre Isoelectrophoretic characterization of protein antigens present in mycobacterial culture filtrates and recognized by monoclonal antibodies directed against the Mycobacterium bovis BCG antigen 85 complex Scand J Immunol 36 November(5) 1992 697 702
18. J. De Bruyn K. Huygen R. Bosmans M. Fauville R. Lippens J.P. Van Vooren Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG Microb Pathog 2 May(5) 1987 351 366
19. T. Gartner M. Baeten S. Otieno H. Revets P. De Baetselier K. Huygen Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85A Immunol Lett 111 2007 26 35
20. S. D'Souza V. Rosseels M. Romano A. Tanghe O. Denis F. Jurion Mapping of murine Th1 helper T-cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis Infect Immun 71 January(1) 2003 483 493
21. b-restricted cytolytic T cell activity against a putative phosphate transport receptor of Mycobacterium tuberculosis J Immunol 172 June 1(11) 2004 6913 6921
22. K. Huygen D. Abramowicz P. Vandenbussche F. Jacobs J. De Bruyn A. Kentos Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice Infect Immun 60 July(7) 1992 2880 2886
23. V.A. Snewin M.P. Gares P.O. Gaora Z. Hasan I.N. Brown D.B. Young Assessment of immunity to mycobacterial infection with luciferase reporter constructs Infect Immun 67 September(9) 1999 4586 4593
24. M. Romano S. D'Souza P.Y. Adnet R. Laali F. Jurion K. Palfliet Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv Vaccine 24 April 12(16) 2006 3353 3364
25. A. Tanghe S. D'Souza V. Rosseels O. Denis T.H. Ottenhoff W. Dalemans Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting Infect Immun 69 May(5) 2001 3041 3047
26. C. Goter-Robinson S.C. Derrick A.L. Yang B.Y. Jeon S.L. Morris Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses Vaccine 24 April 24(17) 2006 3522 3529
27. S. Sasaki K.Q. Xin K. Okudela K. Okuda N. Ishii Immunomodulation by apoptosis-inducing caspases for an influenza DNA vaccine delivered by gene gun Gene Ther 9 June(12) 2002 828 831
28. C.M. Bosio D. Gardner K.L. Elkins Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis : delay in dissemination and development of lung pathology J Immunol 164 June 15(12) 2000 6417 6425
29. C.M. Johnson A.M. Cooper A.A. Frank C.B. Bonorino L.J. Wysoki I.M. Orme Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice Tuber Lung Dis 78 5/6 1997 257 261
30. H.M. Vordermeier N. Venkataprasad D.P. Harris J. Ivanyi Increase of tuberculous infection in the organs of B cell-deficient mice Clin Exp Immunol 106 November(2) 1996 312 316
31. L. Grode P. Seiler S. Baumann J. Hess V. Brinkmann A. Nasser Eddine Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette–Guerin mutants that secrete listeriolysin J Clin Invest 115 September(9) 2005 2472 2479
32. F. Winau S. Weber S. Sad J. de Diego S.L. Hoops B. Breiden Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis Immunity 24 January(1) 2006 105 117
33. J. Hinchey S. Lee B.Y. Jeon R.J. Basaraba M.M. Venkataswamy B. Chen Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis J Clin Invest 117 August(8) 2007 2279 2288
34. M.L. Cho J.H. Ju K.W. Kim Y.M. Moon S.Y. Lee S.Y. Min Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K/Akt and NF-kappaB Immunol Lett 108 January 15(1) 2007 88 96
35. C.L. Langrish Y. Chen W.M. Blumenschein J. Mattson B. Basham J.D. Sedgwick IL-23 drives a pathogenic T cell population that induces autoimmune inflammation J Exp Med 201 January 17(2) 2005 233 240
36. J.K. Kolls A. Lindén Interleukin-17 family members and inflammation Immunity 21 2004 467 476
37. M. Woo R. Hakem C. Furlonger A. Hakem G.S. Duncan T. Sasaki Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity Nat Immunol 4 October(10) 2003 1016 1022
38. M. Lamkanfi N. Festjens W. Declercq T. Vanden Berghe P. Vandenabeele Caspases in cell survival, proliferation and differentiation Cell Death Differ 14 January(1) 2007 44 55
39. L. Santambrogio I. Potolicchio S.P. Fessler S.H. Wong G. Raposo J.L. Strominger Involvement of caspase-cleaved and intact adaptor protein 1 complex in endosomal remodeling in maturing dendritic cells Nat Immunol 6 October(10) 2005 1020 1028
40. O. Sordet C. Rebe S. Plenchette Y. Zermati O. Hermine W. Vainchenker Specific involvement of caspases in the differentiation of monocytes into macrophages Blood 100 December 15(13) 2002 4446 4453
41. M.A. Chattergoon J.J. Kim J.S. Yang T.M. Robinson D.J. Lee T. Dentchev Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis Nat Biotechnol 18 September(9) 2000 974 979
42. T.W. Kim C.F. Hung M. Ling J. Juang L. He J.M. Hardwick Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins J Clin Invest 112 July(1) 2003 109 117